for inclusion – Page 9 – Communicable Diseases Research

A systematic review on SARS‐CoV‐2‐associated fungal coinfections

Review

Published on 2021-10-052022-10-04
Journal: Journal of medical virology [Category] MERS, SARS, 치료기술,

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis

Research article

Published on 2021-10-012022-10-05
Journal: Journal of microbiology, immunology, and infection [Category] SARS, 치료법,

Determining the acceptability of testing contacts of confirmed COVID-19 cases to improve secondary case ascertainment

Original Article

Published on 2021-09-302022-10-30
Journal: Journal of public health (Oxford, England) [Category] COVID-19, SARS,

Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020

2020년 COVID-19 팬데믹 기간 동안 캄보디아 및 광역 메콩 소지역에서 인플루엔자 A(H3N2) 발병의 유전 및 항원 특성 분석

Genetic Diversity and Evolution

Published on 2021-09-292022-09-10
Journal: Journal of Virology [Category] MERS, SARS, 치료기술,

[키워드] 2019 coronavirus disease A(H3N2) Analysis antigenic evolution Asia Cambodia characterization characterized circulation component coronavirus coronavirus disease country COVID-19 decrease Epidemic Epidemics event for inclusion Genetic Hemisphere in some Inclusion Infection Influenza influenza A influenza vaccine Intervention Laos maintenance measure Mekong Migration occurred outbreak pandemic PDR Phylogenetic analysis prototype virus reduction in remained respiratory Respiratory disease respiratory diseases resulting SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 significantly Surveillance the WHO these viruses Vaccine Vietnam virus viruses was performed WHO
[DOI] 10.1128/JVI.01267-21 PMC 바로가기 [Article Type] Genetic Diversity and Evolution

Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities

Original Paper

Published on 2021-09-212022-10-31
Journal: Clinical Research in Cardiology [Category] COVID-19, MERS, SARS,

[키워드] Abstract all-cause mortality analysed Analysis anticoagulation association bleeding event cardiovascular comorbidity Cohort Comorbidities composite endpoint coronavirus disease Course COVID-19 COVID-19 cohort COVID-19-related death death disease eligible Endpoint European for inclusion had no Hospital admission Hospital stay independent intracerebral bleeding less limit Mortality OAC oral anticoagulant Oral anticoagulation outcome outcome measure Patient Protective risk SARS-CoV-2 SARS-CoV-2 infected patient SARS-CoV-2 infected patients SARS-COV-2 infection secondary secondary endpoint shown survey thrombosis thrombotic Venous Thromboembolism
[DOI] 10.1007/s00392-021-01939-3 PMC 바로가기 [Article Type] Original Paper

Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS—a randomized, placebo-controlled, double-blind trial

중등도에서 중증 ARDS 환자의 폐 투과성 부종을 치료하기 위해 순차적으로 다중 상승하는 solnatide의 안전성 및 예비 효능 - 무작위, 위약 대조, 이중 맹검 시험

Randomized Controlled Trial

Published on 2021-09-202022-09-10
Journal: Trials [Category] SARS, 비임상, 임상,

[키워드] acquisition acute respiratory distress syndrome administer alveolar animal model animal models ARDS ARDS patients breath clinical Clinical diagnosis clinical trial collected comatose complex Course Critical care data safety monitoring board decarboxylation diffusion distress dose double-blind double-blind trial edema Efficacy eligible patient Eligible patients Endpoint etiologies EU Clinical Trials EudraCT Extravascular lung water follow-up period for inclusion healthy Human Inclusion Informed consent Inhaled Intervention leads mechanical ventilation moderate moderate to severe monitoring board multiple ascending dose Oxygenation parallel group Particular pathway Patient patient safety peptide phase Phase I clinical trial Placebo placebo-controlled protocol Pulmonary edema pulmonary permeability Randomized receiving reduce Registered respiratory distress Respiratory distress syndrome Safe Safety sedated severe ARDS shown sick Solnatide syndrome treat Trial Trial registration
[DOI] 10.1186/s13063-021-05588-9 PMC 바로가기 [Article Type] Randomized Controlled Trial

Effectiveness and safety of ivermectin in the treatment of COVID-19: protocol for a systematic review and meta-analysis

Covid-19의 치료에서 Ivermectin의 효과 및 안전성 : 체계적인 검토 및 메타 분석을위한 프로토콜

Article

Published on 2021-09-172022-08-31
Journal: BMJ Open [Category] meta-analysis, SARS, 임상,

[키워드] acute respiratory syndrome Admission antiviral properties antiviral property approval assessment Bia bias risk carried clinical clinical pharmacology clinical trial clinical trials Clinical use COVID-19 criteria database development Diagnosis drug Effectiveness eligibility Ethical approval Ethics Evidence extracorporeal membrane oxygenation for inclusion Frequency GRADE hospitalisation in some incidence include Infection Infectious diseases intensive care intensive care unit Invasive mechanical ventilation involved item Ivermectin mean difference Meta-analysis methodology Mortality observational studies observational study outcome outcomes Patient patients with COVID-19 PCR-negative peer-reviewed Placebo Prophylactic PROSPERO protocol public health random-effects model randomised clinical trial Randomised clinical trials Real-time PCR registration number registry Relative risk Reporting required respiratory review risk serology test Severe acute respiratory syndrome Side effects subgroup analysis Support Symptom symptom resolution Symptomatic treatment systematic review systematic reviews the mean Treatment Trial Viral Viral load
[DOI] 10.1136/bmjopen-2021-050532 PMC 바로가기 [Article Type] Article

One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases—Utah and Wisconsin, 2020

인간의 Covid-19 사례가 확인 된 가구의 애완 동물 사이의 SARS-Cov-2 감염 및 혈청 양성에 대한 건강 조사-2020 년 우타와 위스콘신

Article

Published on 2021-09-122022-09-10
Journal: Viruses [Category] Fulltext, SARS, 조류인플루엔자, 치료기술,

Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews

Review

Published on 2021-09-112022-10-31
Journal: Diagnostics [Category] COVID-19,

[키워드] absence addition Administered administration Adverse reactions analyses Analysis Anti-viral therapy Clinical improvement conducted convalescent plasma COVID-19 database disease severity Efficacy and safety estimate evaluated Evidence for inclusion funding source highlight Hospital stay identify inclusion criteria Infection limitation measurement Methodological quality moderate Mortality Neutralizing antibody titer nine outcome overview Patient performed plasma protocol RCT reduction in review risk of bia Safety Standard therapy Study design systematic literature search systematic review therapy unique Variability viral clearance Web of Science
[DOI] 10.3390/diagnostics11091663 PMC 바로가기 [Article Type] Review

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial

주간 17 Alpha-HydroxyProgesterone CABROATE HIV를 가진 여성들 사이에서 조산을 예방하기위한 : 무작위, 이중 맹검, 위약 대조 시험

Articles

Published on 2021-09-092022-09-06
Journal: The Lancet. HIV [Category] Communicable Disease,

[키워드] 1:1 17P 95% CI adherence adverse event adverse events age Anomaly antenatal care Antiretroviral therapy assessments assigned available data baseline characteristics both groups Cervical cerclage Characteristics Complete Composite criteria District double-blind drug during pregnancy early delivery Eligible participants eligible patient Eligible patients enrolled event Evidence evidence of except for exclusion criteria fetal Final finding Follow-up for inclusion foundation funding gestation gestational age group groups HIV infection HIV-1 infection in both groups in some increased risk injection Intention intention to treat intramuscular investigated less Melinda Gate Melinda Gates membrane miscarriage occurred Older participant Participants Patient Placebo placebo-controlled trial Pregnancy pregnant women Preterm birth Prevent Primary outcome proportion provided random assignment randomisation randomised Randomly receive receiving reduce Registered Relative risk reported risk risk difference Safe Serious Adverse Event Serious Adverse Events shown Stillbirth study drug Support Teaching treatment group treatment groups Trial university uterine Weekly were excluded with HIV women written Informed Consent
[DOI] 10.1016/S2352-3018(21)00150-8 PMC 바로가기 [Article Type] Articles